AXDX
Price:
$1.87
Market Cap:
$44.28M
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk....[Read more]
Industry
Medical - Devices
IPO Date
1994-04-07
Stock Exchange
NASDAQ
Ticker
AXDX
According to Accelerate Diagnostics, Inc.’s latest financial reports and current stock price. The company's current ROE is 131.18%. This represents a change of 247.09% compared to the average of 37.80% of the last 4 quarters.
The mean historical ROE of Accelerate Diagnostics, Inc. over the last ten years is 170.63%. The current 131.18% ROE has changed -23.12% with respect to the historical average. Over the past ten years (40 quarters), AXDX's ROE was at its highest in in the December 2019 quarter at 289.13%. The ROE was at its lowest in in the September 2019 quarter at -199.94%.
Average
170.63%
Median
45.15%
Minimum
-153.95%
Maximum
1.14%
Discovering the peaks and valleys of Accelerate Diagnostics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 193.58%
Maximum Annual ROE = 1.14%
Minimum Annual Increase = -842.15%
Minimum Annual ROE = -153.95%
Year | ROE | Change |
---|---|---|
2023 | 309.83% | 10.38% |
2022 | 280.69% | 26.69% |
2021 | 221.56% | 77.94% |
2020 | 124.51% | -89.10% |
2019 | 1.14% | -842.15% |
2018 | -153.95% | 193.58% |
2017 | -52.44% | -38.52% |
2016 | -85.30% | 149.37% |
2015 | -34.20% | -27.03% |
2014 | -46.87% | 27.35% |
The current ROE of Accelerate Diagnostics, Inc. (AXDX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
270.69%
5-year avg
415.82%
10-year avg
170.63%
Accelerate Diagnostics, Inc.’s ROE is greater than CVRx, Inc. (-89.06%), greater than NeuroPace, Inc. (-195.26%), greater than Anika Therapeutics, Inc. (-48.10%), greater than AxoGen, Inc. (-17.30%), greater than Artivion, Inc. (-2.92%), greater than Sight Sciences, Inc. (-45.68%), greater than Orthofix Medical Inc. (-20.68%), greater than Avanos Medical, Inc. (1.28%), less than CONMED Corporation (15.04%), greater than OrthoPediatrics Corp. (-6.73%), greater than Surmodics, Inc. (-1.16%), less than Integer Holdings Corporation (7.30%), less than ProSomnus, Inc. Common Stock (50.75%), less than LivaNova PLC (1.87%), less than Electromed, Inc. (12.44%), greater than Pulmonx Corporation (-53.88%), less than IRadimed Corporation (23.98%),
Company | ROE | Market cap |
---|---|---|
-89.06% | $327.87M | |
-195.26% | $185.98M | |
-48.10% | $252.58M | |
-17.30% | $622.38M | |
-2.92% | $1.15B | |
-45.68% | $234.43M | |
-20.68% | $661.57M | |
1.28% | $882.83M | |
15.04% | $2.18B | |
-6.73% | $695.92M | |
-1.16% | $536.01M | |
7.30% | $4.24B | |
50.75% | $8.18M | |
1.87% | $2.66B | |
12.44% | $191.38M | |
-53.88% | $278.77M | |
23.98% | $625.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Accelerate Diagnostics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Accelerate Diagnostics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Accelerate Diagnostics, Inc.'s ROE?
How is the ROE calculated for Accelerate Diagnostics, Inc. (AXDX)?
What is the highest ROE for Accelerate Diagnostics, Inc. (AXDX)?
What is the 3-year average ROE for Accelerate Diagnostics, Inc. (AXDX)?
What is the 5-year average ROE for Accelerate Diagnostics, Inc. (AXDX)?
How does the current ROE for Accelerate Diagnostics, Inc. (AXDX) compare to its historical average?